Stockholm - Free Realtime Quote SEK

Oncopeptides AB (publ) (ONCO.ST)

1.5840

+0.0280

(+1.80%)

As of 4:17:07 PM GMT+1. Market Open.

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ...

Oncopeptides AB (STU:OND) reports increased revenue and cost efficiency, while navigating market challenges and focusing on key European markets.

GuruFocus.com last month

ONCO.ST
+1.80%
Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients

ZURICH and ZUG, Switzerland and STOCKHOLM, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Veld Pharmaceuticals GmbH (“Veld”) and Slavpharma GmbH (“Slavpharma”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in Africa and Eurasia. Under the terms of this exclusive agreement, Veld and Slavpharma will distribute Pepaxti to patients in their respective regions f

GlobeNewswire 3 months ago

ONPPF
Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

DUBAI, United Arab Emirates and STOCKHOLM, Sweden, March 27, 2024 (GLOBE NEWSWIRE) -- Oncopeptides AB (STO: ONCO), a biotech company focused on difficult-to-treat cancers, and Vector Pharma FZCO (“Vector”) today announced a collaboration to commercialize Oncopeptides’ flagship drug Pepaxti (melphalan flufenamide) in the Middle East and North Africa (“MENA”) countries of Saudi Arabia, Qatar, UAE, Bahrain, Kuwait, Oman, Algeria, Tunisia, Morocco, Libya, Lebanon, and Iraq. Under the terms of this e

GlobeNewswire 9 months ago

ONPPF

Performance Overview

Return	ONCO.ST	OMX Stockholm 30 Index
YTD	+1.80%	+0.89%
1-Year	-79.32%	+4.47%
3-Year	-81.14%	+3.54%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Oncopeptides AB (publ) (ONCO.ST)

Oncopeptides AB (STU:OND) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic Market ...

Oncopeptides expands on WODA partnership with addition of Africa and Eurasia to provide Pepaxti to Patients

Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa

Performance Overview